Jérémie Richard, Ph.D.
@JRichardPhD
Assistant Professor @uOttawa • Counselling Psychologist • Affiliate Researcher @JHPsychedelics • @mcgillu alumnus • Mental Health and Addiction Research
If you or anyone you know has struggled with a behavioral addiction and taken a psychedelic substance, we would greatly appreciate learning more about your experience. Please follow the link below to participate in our survey / optional interview. hopkinspsychedelic.org/addictionsurvey
Have you struggled with a behavioral addiction and taken a psychedelic substance in the past? We are seeking individuals to participate in a research study looking into the effects of psychedelics on a number of addictive behaviors including problems with gambling, video gaming,…
The 2024 conference in New Orleans was incredible. I highly recommend to anyone interested in psychedelic research ranging from preclinical to clinical investigations.
We're thrilled to announce that ISRP 2026 abstract submission will open on August the 15th! Join us in New Orleans from Feb 27 - Mar 1 Oral presentations will be 15 min + 5 min Q&A Stay tuned for more updates! Please note only ISRP members are eligible to submit an abstract
Associate Director, Dr. Albert Garcia-Romeu shared his insights on psychedelic therapies for psychiatric disorders. He explains the science, shifting public perception, and potential for future FDA approval for these therapies.
Amazing pre-clinical poster session at #GRCPsychedelics. Play the "Where's Waldo" of @JHPsychedelics postdocs and faculty. 5 is the number to beat.
Poster session in full swing. Lots of exciting unpublished work. #GRCPsychedelics
Last week, CPCR researchers Drs. Fred Barrett, Brandon Weiss, David Yaden, and Sandeep Nayak met with the PATH Caucus (led by @RepLouCorrea and @RepJackBergman) on Capitol Hill. In a vibrant meeting of oral presentations and Q&A, Drs. Barrett and Weiss shared their scientific…
The Psychedelic Assisted Therapy Caucus (PATH) looks to bring psychedelic therapies to cure invisible wounds veterans bring back from the battlefield. At yesterday's PATH Caucus meeting, we hosted John Hopkins Medical School Doctors Barrett and Weiss, who presented their…
CPCR is hiring a postdoc to manage the operation of clinical drug trials focused on the treatment of PTSD with psychedelic therapy. Read more below!
Join our brain stimulation research study! Researchers at Johns Hopkins are investigating the effects of psilocybin—a psychoactive compound found in mushrooms—on brain activity and function using transcranial magnetic stimulation, EEG, fMRI, and cognitive testing. Scan the QR…
RCT: Stratifying individuals by baseline negative affect circuit profiles found that 120mg of MDMA improved neural and behavioral responses in those with heightened amygdala reactivity. ja.ma/4jwVUvI @warmxue @LMWilliams_PhD @Stanford_PMHW
📢 Call for papers: Special issue on psychedelics in Brain and Behavior. Submissions open until October 2025. Full details here: onlinelibrary.wiley.com/page/journal/2…